IL10 and neoplasm: Angiopoietin 2 (ANGPT2) negatively influences tumor immunity by stimulating Tie-2-expressing monocytes/macrophages to secrete IL-10, leading to the expansion of Treg cells and inhibiting effector T-cell activation [38,39].